Napp Pharmaceuticals

Napp Pharmaceuticals Limited is a private pharmaceutical company in Cambridge, United Kingdom that was founded in 1923[3][4] and bought by the Sackler family in 1966.[5][6] Headquartered together with the related Napp Research Centre in the Cambridge Science Park since the 1980's,[4] it is a sister company of Purdue Pharma and Mundipharma, all of which are owned by the descendants of Mortimer and Raymond Sackler.

A 10mg MS Continus-branded extended-release morphine tablet displaying the Napp logo. This tablet was manufactured by Bard Pharmaceuticals Ltd,[1] a subsidiary of Napp pharmaceuticals,[2] and distributed by Mundipharma.
The headquarters of Napp Pharmaceuticals, located in the Cambridge Science Park.

The company produces an array of pharmaceutical products, many for pain management, among them branded forms of oxycodone that have been identified as key drugs in the opioid epidemic.[7][8]

In the early 1970s, scientists at Napp developed a delivery system whereby a pill would slowly absorbed by the body, thereby continuously delivering a drug over a 12 hour period.[9] This Continus® delivery system was used by Purdue first to introduce MS Continus in 1987 and Oxycontin eight years later.

References
  1. Food and Drug Administration Philippines Human Drugs Registration Number DR-XY13020 via the FDA Verification Portal.
  2. "Our structure". Napp. Retrieved 9 June 2021. Whilst our commercial focus is in the UK, we are part of the Napp Pharmaceutical Holdings Limited group of companies, which includes Bard Pharmaceuticals Limited, a Cambridge-based production and supply chain company, which manufactures and exports medicines to over 40 countries worldwide.{{cite web}}: CS1 maint: url-status (link)
  3. Posner, Gerald (11 March 2020). "On Terminal Pain and the Origins of the End-of-Life Movement". Literary Hub. Retrieved 9 June 2021.{{cite web}}: CS1 maint: url-status (link)
  4. "100 Best Companies to Work For in the UK: 12. Napp Pharmaceutical Holdings". The Sunday Times. 9 March 2008. ISSN 0140-0460. Retrieved 9 June 2021.
  5. Clary, Sheela (21 April 2021). "Book Review: Patrick Radden Keefe's Empire of Pain". The Berkshire Edge. Retrieved 9 June 2021.{{cite web}}: CS1 maint: url-status (link)
  6. "Raymond Sackler, pharmaceutical entrepreneur and philanthropist – obituary". The Telegraph. 19 July 2017. ISSN 0307-1235. Retrieved 9 June 2021.
  7. Rebecca L. Haffajee, Michelle M. Mello (17 December 2017). "Drug Companies' Liability for the Opioid Epidemic". New England Journal of Medicine. doi:10.1056/NEJMp1710756.
  8. David Armstrong (21 February 2019). "Sackler Embraced Plan to Conceal OxyContin's Strength From Doctors, Sealed Testimony Shows". ProPublica. Retrieved 27 February 2019.
  9. David Crowe (8 September 2018). "What next for the Sacklers? A pharma dynasty under siege". Financial Times. Retrieved 24 February 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.